Voyager Acquisition Corp. operates as a blank check company. It was formed for the purpose of effecting a merger, capital stock exchange, asset acquisition, stock purchase, reorganization, or similar business combination with one or more businesses. The company was founded on December 19, 2023 and is headquartered in Brooklyn, NY.
Sector:
Health Technology
Industry:
Pharmaceuticals Major
Employees:
3
Frequently Asked Questions
What is Market Cap of Veraxa Biotech AG?
Market cap, also known as market capitalization, is the total market value of a company. It's calculated by multiplying the current market price by the total number of shares outstanding. Veraxa Biotech AG market cap is $632.5M.
What is the 52-week high for Veraxa Biotech AG?
52 week high is the highest price of a stock in the past 52 weeks, or one year. Veraxa Biotech AG 52 week high is $27.36 as of June 13, 2026.
What is the 52-week low for Veraxa Biotech AG?
52 week low is the lowest price of a stock in the past 52 weeks, or one year. Veraxa Biotech AG 52 week low is $15.25 as of June 13, 2026.
What is Veraxa Biotech AG stock price today?
Veraxa Biotech AG stock price today is $20.00.
What was Veraxa Biotech AG stock price yesterday?
Veraxa Biotech AG stock price yesterday was $24.79.
What is the PE ratio of Veraxa Biotech AG?
The Price-to-Earnings (or P/E) ratio is a commonly used tool for valuing a company. It's calculated by dividing the current share price by the earnings per share (or EPS). It can also be calculated by dividing the company's Market Cap by the Net Profit. Veraxa Biotech AG's P/E ratio is 93.37.
What is the Price-to-Book ratio of Veraxa Biotech AG?
The Price-to-Book (P/B) ratio is a commonly used tool for valuing a company. It's calculated by dividing a company's market capitalization by its book value. Veraxa Biotech AG P/B ratio is -8.8699.
What is the 50-day moving average of Veraxa Biotech AG?
The 50-day moving average is a frequently used data point by active investors and traders to understand the trend of a stock. It's calculated by averaging the closing stock price over the previous 50 trading days. Veraxa Biotech AG 50-day moving average is $22.40.